![Foto de Jesús María](/img/nophoto.png)
Jesús María
Hernández Rivas
Publikationen, an denen er mitarbeitet Jesús María Hernández Rivas (4)
2020
-
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients
Pharmacogenomics Journal, Vol. 20, Núm. 5, pp. 664-671
-
miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk
Leukemia, Vol. 34, Núm. 10, pp. 2648-2659
2017
2009
-
P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)
Leukemia Research, Vol. 33, Núm. SUPPL. 1